Liquidia (LQDA) EBITDA Margin (QoQ) (2021 - 2026)
Liquidia (LQDA) EBITDA Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Liquidia | 6.33 Bn | 6.05 Bn | 160.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 352.00 |
| Mar 31, 2026 | 2,479.00 |
| Dec 31, 2025 | 1,825.00 |
| Sep 30, 2025 | 42,766.00 |
| Jun 30, 2025 | 71,101.00 |
| Mar 31, 2025 | 10,240.00 |
| Dec 31, 2024 | -58,159.00 |
| Sep 30, 2024 | 8,706.00 |
| Jun 30, 2024 | 22,579.00 |
| Mar 31, 2024 | -38,563.00 |
| Dec 31, 2023 | -17,858.00 |
| Sep 30, 2023 | 7,205.00 |
| Jun 30, 2023 | -27,144.00 |
| Mar 31, 2023 | -8,426.00 |
| Dec 31, 2022 | 15,781.00 |
| Sep 30, 2022 | -5,008.00 |
| Jun 30, 2022 | 18,549.00 |
| Mar 31, 2022 | -6,103.00 |
| Dec 31, 2021 | -13,069.00 |
| Sep 30, 2021 | -3,450.00 |